Please try another search
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Name | Age | Since | Title |
---|---|---|---|
Sina Habibi | - | 2017 | Co-Founder, CEO & Director |
James O'Shaughnessy | - | 2021 | Member of Advisory Board |
David Velisek | 49 | 2015 | Independent Director |
John Edward Kitson Smith | 67 | 2021 | Member of Advisory Board |
Keith George Gibbs | 63 | 2019 | Member of Advisory Board |
Carol Routledge | - | 2021 | Member of Advisory Board |
Dag Aarsland | - | 2021 | Member of Advisory Board |
Mark A. Phillips | - | 2017 | Director |
Desmond M. Balakrishnan | 51 | 2021 | Legal Counsel & Director |
Christos Kalafatis | - | 2017 | Director |
Jonathan El-Sharkawy | - | 2023 | Member of Advisory Board |
Thomas Roger Sawyer | 53 | 2017 | CFO, Company Secretary & Director |
Karimah Es Sabar | 65 | 2023 | Director |
Lance Black | - | 2022 | Member of Advisory Board |
Duncan Allen | - | 2022 | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review